Showing results (71-80 of 323) with videos related to
Sort By:
Pageof 33
Clinical and Experimental Immunology|September 1, 1987
Erythrocytes transfused into patients with SLE and haemolytic anaemia lose complement receptor type 1 from their cell surfaceM Walport, Y C Ng, P J LachmannJournal of Immunogenetics|June 1, 1978
Inherited structural variation and linkage relationships of C7M J Hobart, V Joysey, P J LachmannBiochemical and Biophysical Research Communications|October 16, 1989
A novel strategy for producing chimeric bispecific antibodies by gene transfectionS Songsivilai, P M Clissold, P J LachmannScandinavian Journal of Immunology|March 1, 1988
The killing of tumour cell targets coupled to tuberculin (PPD) by human and murine PPD-reactive T helper clones. I. PPD specificity of killingA Vyakarnam, P J Lachmann, D Y SiaClinical and Experimental Immunology|March 1, 1983
Further studies of the C3g component of the alpha 2D fragment of human C3H Chaplin, M C Monroe, P J LachmannBiochemical Society Transactions|March 10, 2019
On fitness: how do mutations shape the biology of cancer?Ian J MajewskiEuropean Journal of Immunology|September 1, 1993
Construction, expression and functional analysis of a glycolipid-linked form of CR1P M Clissold, H J Ebling, P J LachmannJournal of Immunology (Baltimore, Md. : 1950)|May 1, 1985
Membrane complement receptor type three (CR3) has lectin-like properties analogous to bovine conglutinin as functions as a receptor for zymosan and rabbit erythrocytes as well as a receptor for iC3bG D Ross, J A Cain, P J LachmannJournal of Immunology (Baltimore, Md. : 1950)|October 1, 1979
Activation of complement by Schistosoma mansoni schistosomula: killing of parasites by the alternative pathway and requirement of IgG for classical pathway activationF Santoro, P J Lachmann, A Capron, et al.Immunology|February 1, 1992
The targeting of T-helper cells and tumourcidal macrophages to a B-cell lymphoma using a PPD-monoclonal antibody heteroconjugateA M Montgomery, M G Wing, P J LachmannPageof 33